2,000 Shares in Tempus AI, Inc. $TEM Bought by Trifecta Capital Advisors LLC

Trifecta Capital Advisors LLC acquired a new position in shares of Tempus AI, Inc. (NASDAQ:TEM) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 2,000 shares of the company’s stock, valued at approximately $127,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of TEM. Cherry Tree Wealth Management LLC acquired a new position in Tempus AI during the first quarter worth $31,000. University of Texas Texas AM Investment Management Co. acquired a new position in Tempus AI during the first quarter worth $33,000. Continuum Advisory LLC acquired a new position in Tempus AI during the first quarter worth $39,000. Bartlett & CO. Wealth Management LLC grew its holdings in Tempus AI by 100.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company’s stock worth $39,000 after acquiring an additional 400 shares during the period. Finally, Nemes Rush Group LLC acquired a new position in Tempus AI during the first quarter worth $39,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Eric P. Lefkofsky sold 332,500 shares of the company’s stock in a transaction on Thursday, September 25th. The stock was sold at an average price of $76.56, for a total value of $25,456,200.00. Following the sale, the chief executive officer directly owned 9,141,032 shares in the company, valued at $699,837,409.92. This represents a 3.51% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Erik Phelps sold 3,664 shares of the company’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $273,517.60. Following the completion of the sale, the executive vice president owned 94,115 shares in the company, valued at $7,025,684.75. This represents a 3.75% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 933,662 shares of company stock valued at $68,070,993. Insiders own 26.27% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on TEM. Bank of America upped their price objective on Tempus AI from $68.00 to $70.00 and gave the stock a “neutral” rating in a report on Wednesday, June 25th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Tempus AI in a research report on Wednesday. Morgan Stanley boosted their target price on Tempus AI from $65.00 to $68.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 12th. HC Wainwright boosted their target price on Tempus AI from $90.00 to $98.00 and gave the stock a “buy” rating in a research report on Friday, September 12th. Finally, Guggenheim boosted their target price on Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, September 26th. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Tempus AI has a consensus rating of “Hold” and a consensus price target of $71.83.

Tempus AI Stock Up 11.0%

Shares of NASDAQ:TEM opened at $103.25 on Thursday. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. Tempus AI, Inc. has a 52-week low of $31.36 and a 52-week high of $103.42. The stock’s fifty day simple moving average is $77.21 and its 200-day simple moving average is $64.16. The company has a market capitalization of $17.94 billion, a P/E ratio of -86.76 and a beta of 4.87.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings data on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The business had revenue of $314.64 million for the quarter, compared to the consensus estimate of $296.84 million. During the same period in the prior year, the business earned ($6.86) earnings per share. The business’s revenue was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. As a group, equities research analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.